Natco Pharma and Breckenridge Pharmaceutical Launch Generic Everolimus Tablets in the U.S.

Unknown Apr 02, 2026 4 Views

Natco Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the immediate U.S. launch of generic Everolimus Tablets for Oral Suspension, following final approval from the U.S. Food and Drug Administration (FDA). These tablets, available in 2 mg, 3 mg, and 5 mg stren...

Stay Ahead – Explore Now! Swadeshi Industries Approves Conversion of 12.3 Million Warrants into Equity Shares